Explore the latest in multiple sclerosis, including the epidemiology, etiology, diagnosis, imaging, and management of the disorder.
This Viewpoint encourages using the deliberative model in treating and communicating with patients with relapsing-remitting multiple sclerosis.
This cohort study examines the association of superimposed relapses in progressive-onset multiple sclerosis on disease outcomes.
This study evaluates the diagnostic accuracy of the 2017 McDonald criteria vs the 2010 criteria to predict clinically definite multiple sclerosis in patients with a typical clinically isolated syndrome.
This systematic review and meta-analysis of 17 randomized clinical trials including 3161 patients examines the association of efficacy and tolerability of cannabinoids with spasticity, pain, and bladder dysfunction in patients with multiple sclerosis (MS).
This cohort study assesses the dynamics of brain volume loss after multiple sclerosis onset and evaluates the repeatability of brain volume loss estimates made via 2 magnetic resonance imaging protocols.
This longitudinal cohort study investigates the association of retinal optical coherence tomographic results with future disease activity in patients with clinically isolated syndrome.
This review discusses the current state of evidence for the role that vitamins and dietary supplements play in multiple sclerosis and its animal models, with an emphasis on recent studies, and addresses biological plausibility and safety issues.
This Viewpoint summarizes the current knowledge of the clinical, radiologic, and immunologic features of adult patients who are positive for anti–myelin oligodendrocyte glycoprotein and compares these individuals with patients with multiple sclerosis and patients with neuromyelitis optica.
This Viewpoint discusses the validity of using a strategy of targeting no evident disease activity to treat relapsing multiple sclerosis.
This case report describes a patient with relapsing-remitting multiple sclerosis treated with dimethyl fumarate who developed Listeria monocytogenes infection complicated by rhombencephalitis.
This case report examines the aquaporin-4–IgG and myelin oligodendrocyte glycoprotein–IgG serostatus of patients within the Optic Neuritis Treatment Trial and describes the clinical features of seropositive patients.
This cohort study evaluates the differences in response to apheresis treatment of patients with 3 histopathologically defined immunopathological patterns of multiple sclerosis.
This multinational cohort study examines the clinical phenotypes, treatment responses, and outcomes of children with relapsing myelin oligodendrocyte glycoprotein antibody–associated disease.
This observational cohort study assesses the effectiveness and drug discontinuation rates of rituximab among patients with newly diagnosed relapsing-remitting multiple sclerosis compared with injectable disease-modifying treatments, dimethyl fumarate, fingolimod, or natalizumab.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: